Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease
- PMID: 12074273
- DOI: 10.1253/circj.66.561
Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease
Abstract
The homeobox transcription factor CSX/NKX2.5, which is a vertebrate homologue of the Drosophila gene tinman, is essential for cardiac development. It is expressed in the early cardiac mesoderm and in heart muscle lineage throughout life. Homozygous deletion of CSX/NKX2.5 causes early embryonic lethality in mice because cardiac development is arrested at the linear heart tube stage. Heterozygous mutation of human CSX/NKX2.5 has been associated with various congenital heart diseases such as atrial septal defect (ASD), ventricular septal defect, tetralogy of Fallot, and tricuspid valve abnormalities, including Ebstein's anomaly. Additionally, CSX/NKX2.5 mutation causes atrioventricular (AV) conduction block with or without associated congenital heart diseases. Ten different heterozygous mutations have been already reported and a new point mutation, which is a C-to-A transition (Cys264ter) at nucleotide 901 of CSX/NKX2.5, results in the production of a truncated protein occurring COOH-terminal to the homeodomain of CSX/NKX2.5. The mutation was found in a patient with familial ASD and first-degree AV block; 4 members from 3 generations had secundum-type ASD and first-degree AV block.
Similar articles
-
Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome.J Am Coll Cardiol. 2003 Jun 4;41(11):2072-6. doi: 10.1016/s0735-1097(03)00420-0. J Am Coll Cardiol. 2003. PMID: 12798584
-
A novel CSX/NKX2-5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype?Eur J Hum Genet. 2006 Dec;14(12):1313-6. doi: 10.1038/sj.ejhg.5201702. Epub 2006 Aug 9. Eur J Hum Genet. 2006. PMID: 16896344
-
Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.J Clin Invest. 1999 Dec;104(11):1567-73. doi: 10.1172/JCI8154. J Clin Invest. 1999. PMID: 10587520 Free PMC article.
-
Cardiac transcription factor Csx/Nkx2-5: Its role in cardiac development and diseases.Pharmacol Ther. 2005 Aug;107(2):252-68. doi: 10.1016/j.pharmthera.2005.03.005. Pharmacol Ther. 2005. PMID: 15925411 Review.
-
Developmental paradigms in heart disease: insights from tinman.Ann Med. 2002;34(3):148-56. Ann Med. 2002. PMID: 12173684 Review.
Cited by
-
Novel NKX2-5 mutations in diseased heart tissues of patients with cardiac malformations.Am J Pathol. 2004 Jun;164(6):2117-25. doi: 10.1016/S0002-9440(10)63770-4. Am J Pathol. 2004. PMID: 15161646 Free PMC article.
-
Novel NKX2-5 mutations in patients with familial atrial septal defects.Pediatr Cardiol. 2011 Feb;32(2):193-201. doi: 10.1007/s00246-010-9859-6. Epub 2010 Dec 25. Pediatr Cardiol. 2011. PMID: 21188375
-
Nkx2-5 Regulates Tdgf1 (Cripto) Early During Cardiac Development.J Clin Exp Cardiolog. 2012;Suppl 11:1-4. doi: 10.4172/2155-9880.S11-003. J Clin Exp Cardiolog. 2012. PMID: 24069547 Free PMC article.
-
Familial Atrial Septal Defect and Sudden Cardiac Death: Identification of a Novel NKX2-5 Mutation and a Review of the Literature.Congenit Heart Dis. 2016 May;11(3):283-90. doi: 10.1111/chd.12317. Epub 2015 Dec 18. Congenit Heart Dis. 2016. PMID: 26679770 Free PMC article. Review.
-
Single nucleotide editing without DNA cleavage using CRISPR/Cas9-deaminase in the sea urchin embryo.Dev Dyn. 2017 Dec;246(12):1036-1046. doi: 10.1002/dvdy.24586. Epub 2017 Oct 13. Dev Dyn. 2017. PMID: 28857338 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials